Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Haematologica
|
February 4, 2017
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Mika Shapiro, Yair Herishanu, Ben-Zion Katz, et al.
Leukemia & Lymphoma
|
June 9, 2020
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors
Christopher Pleyer, Clare Sun, Sanjal Desai, et al.
Leukemia & Lymphoma
|
March 18, 2021
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma
Jayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, et al.
Leukemia & Lymphoma
|
May 10, 2018
Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes
Sreenivasulu Gunti, Sarah E M Herman, Raju V S R K Gottumukkala, et al.
Cancer Research Communications
|
March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
McKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Heart Rhythm
|
October 12, 2025
Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib
Emily Tomasulo, Andy Itsara, Mark Haigney, et al.
Blood
|
May 28, 2021
BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL
Maissa Mhibik, Erika M Gaglione, David Eik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 12, 2025
Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab
Rui Mu, Katherine M Hornick, Neelam Redekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2020
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
Anfal Alsadhan, Jean Cheung, Michael Gulrajani, et al.
Molecular Oncology
|
August 31, 2013
p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia
Jun Zhang, Christopher S Seet, Clare Sun, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Haematologica
|
February 4, 2017
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia
Mika Shapiro, Yair Herishanu, Ben-Zion Katz, et al.
Leukemia & Lymphoma
|
June 9, 2020
Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors
Christopher Pleyer, Clare Sun, Sanjal Desai, et al.
Leukemia & Lymphoma
|
March 18, 2021
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma
Jayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, et al.
Leukemia & Lymphoma
|
May 10, 2018
Polyreactive antibodies in CLL correlate with the level of immunoglobulins not the number of B lymphocytes
Sreenivasulu Gunti, Sarah E M Herman, Raju V S R K Gottumukkala, et al.
Cancer Research Communications
|
March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
McKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Heart Rhythm
|
October 12, 2025
Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib
Emily Tomasulo, Andy Itsara, Mark Haigney, et al.
Blood
|
May 28, 2021
BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL
Maissa Mhibik, Erika M Gaglione, David Eik, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 12, 2025
Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab
Rui Mu, Katherine M Hornick, Neelam Redekar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2020
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib
Anfal Alsadhan, Jean Cheung, Michael Gulrajani, et al.
Molecular Oncology
|
August 31, 2013
p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia
Jun Zhang, Christopher S Seet, Clare Sun, et al.
Page
of 6